Some solid revenue growth for Medtronic, compared with the same quarter a year ago, were somewhat spoiled by a $200 million write down following the poor outcome from its much vaunted Symplicity HTN-3 Study.
Company News
Sorin Doesn’t Let an Earthquake Halt Profit Progress
Sorin’s financials for 2013 look pretty punchy and despite a few product-lifecycle challenges appear to indicate that the financial impact of the recent earthquake experienced at one of the company’s facilities are well behind it.
Eventful 2014 Expected for Thoratec® Heart Assist Devices
While Thoratec’s numbers landed within their guidance figures, we somehow expected to see more from a company that purports to be changing the face of the heart-assist device world. The mood music suggests they’re readying themselves for acceleration beyond 2014 though.